News

New Brain Tumor Clinical Trials: July- December 2022 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for patients with a primary brain tumor*. Follow the hyperlink above to learn more about […] January 20, 2023

Breakthroughs Ahead: Liz Salmi National Brain Tumor Society board member Liz Salmi and her husband Brett have been living with her grade 2 astrocytoma diagnosis for 15 years. We’re so grateful for her service and for allowing us to share her story with our community. Watch Liz’s video and learn how their experiences have led them to champion the […] December 5, 2022

Q&A: A New Treatment Approved for Certain Brain Tumors In late June 2022, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new treatment combination that will now be available as an option for certain brain tumor patients. The approved combination of two oral drugs, called dabrafenib (brand name: Tafinlar) and trametinib (brand name: Mekinist), is for the treatment of advanced tumors […] August 9, 2022

New Brain Tumor Clinical Trials: January – June 2022 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for primary brain tumor patients*. To learn more about each trial, and to contact the […] July 5, 2022

Guest Blog: Training for the Boston Marathon Gave Me the Push I Needed by Mike Squillante A few hundred feet from the 2022 Boston Marathon finish line, I saw my pregnant wife, Michele, on my right-hand side. A rush of emotions overcame me at that moment. Only 235 days earlier, doctors diagnosed me with a brain tumor.  On August 26, 2021, my wife Michele, our then 8-month-old son Henry, […] April 25, 2022